Search company, investor...

Artisan Pharma

artisanpharma.net

Founded Year

2006

Stage

Acquired | Acquired

Total Raised

$79.4M

About Artisan Pharma

Artisan Pharma is a developer of a biotech drug for a blood-clotting condition in sepsis patients. In November 2011, Asahi Kasei Pharma Corp. today announced its acquisition of Artisan Pharma, Inc., establishing it as a wholly-owned subsidiary. As part of this acquisition, Artisan changed its name to Asahi Kasei Pharma America Corp. (AKP America). The transaction established a United States presence for Asahi Kasei Pharma and also provides access to the global development and commercialization of ART-123 (recombinant human thrombomodulin alpha, marketed as RecomodulinA in Japan) in severe sepsis patients with coagulopathy. Asahi Kasei Pharma established Artisan Pharma (now AKP America) in 2006 with several venture capital firms, licensing ART-123 to Artisan for global development.

Headquarters Location

230 Third Avenue

Waltham, Massachusetts, 02451,

United States

781.419.1919

Missing: Artisan Pharma's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Artisan Pharma's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Artisan Pharma News

Asahi Kasei Pharma America Corp. formerly Artisan Pharma Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 28, 2016

Advertisement Topics   Track topics on Twitter Track topics that are important to you Printed From BioPortfolio.com Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Home » Topics » Biotechnology Business » Latest News » Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc. since January 2007. Key Findings Provides intelligence on Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Artisan Pharma Frequently Asked Questions (FAQ)

  • When was Artisan Pharma founded?

    Artisan Pharma was founded in 2006.

  • Where is Artisan Pharma's headquarters?

    Artisan Pharma's headquarters is located at 230 Third Avenue, Waltham.

  • What is Artisan Pharma's latest funding round?

    Artisan Pharma's latest funding round is Acquired.

  • How much did Artisan Pharma raise?

    Artisan Pharma raised a total of $79.4M.

  • Who are the investors of Artisan Pharma?

    Investors of Artisan Pharma include Asahi Kasei, NGN Capital, EDBI, JAFCO Life Science Investment, QHP Capital and 4 more.

  • Who are Artisan Pharma's competitors?

    Competitors of Artisan Pharma include Hawaii Biotech, Biodel, Viventia, Aduro BioTech, Ascendis Pharma and 12 more.

Compare Artisan Pharma to Competitors

T
TechnoVax

TechnoVax is a privately held biotechnology company and specializes in vaccine development. The company aims to begin clinical trials within the next 18 months.

G
Greenovation Biotech

greenovation Biotech GmbH is engaged in the production of pharmaceutically highly-efficient glycoproteins

B
BioJENC

BioJENC is a biotech company developing peptide vacines against human immunodeficiency virus (HIV) and other challenging infectious agents.

E
Excelsyn

Excelsyn integrate specialist management consulting, chemistry and engineering to offer a range of solutions that can enhance performance across the whole pharmaceuticals, biotech and chemicals value chain.

m
m-Phasys

M-fold Biotech recently emerged from former m-phasys GmbH. Based on technology and many years of experience in protein chemistry the company provide services to the pharma and biotech industry.nThe scalable M-FOLD technology platform aims to give access to purified functional membrane receptors and ion channels. Those products offer applications in areas as diverse as antibody generation, structure analysis and assay development.

C
CELBIO SpA

SiTec Consulting was established in 1996, on the basis of long experience in pharmaceutical R&D. The company developed a range of expertise working with pharmaceutical and biotech companies in the United States and in Europe.n SiTec Consulting offers pharmaceutical and biotechnology companies a variety of services in the areas of preformulation, drug development, drug delivery and formulation technologies evaluation, regulatory and cGLP/cGMP compliance. The company can actively collaborate with start-up pharmaceutical and drug delivery companies to provide scientific and strategic support in the establishment of the new company's activities. The company emphasize open communication, active involvement with the client and continuous feedback.n Networking is one of the company's assets, allowing us to cover the complex demands of the R&D process. The company have access to laboratories and equipment and resources, located at the Bioindustry Park Canavese, and at selected universities and research centers in Europe. This aims to give the possibility to conduct and manage experimental parts of projects at the company's clients' request.n The company value the importance of high quality training. In addition to the hands-on experience the company can provide to the company's clients, SiTec is an authorized representative of the Center for Professional Advancement, a worldwide private institution dedicated to the provision of continuing technical and scientific education at a professional level.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.